Doyugan, Jhaya Mhar P.
HRN: 27-16-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2025
AMPICILLIN 1GM (VIAL)
05/23/2025
05/30/2025
IV
2g
Q6hr
PROM X 30 Mins; THICKLY MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes